Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
$922M |
| 2 |
EOG Resources
EOG
|
$517M |
| 3 |
Mastercard
MA
|
$436M |
| 4 |
Las Vegas Sands
LVS
|
$385M |
| 5 |
Booking.com
BKNG
|
$382M |
Top Sells
| 1 |
Qualcomm
QCOM
|
$660M |
| 2 |
Morgan Stanley
MS
|
$519M |
| 3 |
PayPal
PYPL
|
$479M |
| 4 |
Meta Platforms (Facebook)
META
|
$478M |
| 5 |
Pfizer
PFE
|
$405M |
Sector Composition
| 1 | Technology | 24.82% |
| 2 | Financials | 12.45% |
| 3 | Healthcare | 12.44% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Industrials | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Telesat
TSAT
$342M
| $602K | ﹤0.01% |
31,999
-9,902
| -24% | -$186K |
|
2927
Harvard Bioscience
HBIO
$21.3M
| $600K | ﹤0.01% |
101,175
+10,164
| +11% | +$60.3K |
|
2928
Sight Sciences
SGHT
$193M
| $599K | ﹤0.01% |
39,895
+25,579
| +179% | +$384K |
|
2929
Victory Capital Holdings
VCTR
$4.77B
| $598K | ﹤0.01% |
19,181
+2,283
| +14% | +$71.2K |
|
2930
CoreCard
CCRD
$212M
| $597K | ﹤0.01% |
18,708
-3,273
| -15% | -$104K |
|
|
FUV
2931
DELISTED
Arcimoto, Inc. Common Stock
FUV
| $596K | ﹤0.01% |
4,292
+56
| +1% | +$7.78K |
|
2932
Cardiff Oncology
CRDF
$144M
| $595K | ﹤0.01% |
249,912
-102,755
| -29% | -$245K |
|
2933
FS Bancorp
FSBW
$321M
| $595K | ﹤0.01% |
19,440
-714
| -4% | -$21.9K |
|
2934
INNOVATE Corp
VATE
$75.2M
| $592K | ﹤0.01% |
15,593
-10,523
| -40% | -$400K |
|
2935
Rekor Systems
REKR
$138M
| $588K | ﹤0.01% |
129,969
+4,222
| +3% | +$19.1K |
|
2936
Cambium Networks
CMBM
$18.4M
| $587K | ﹤0.01% |
23,304
-42,977
| -65% | -$1.08M |
|
2937
Daktronics
DAKT
$854M
| $586K | ﹤0.01% |
143,615
+604
| +0.4% | +$2.47K |
|
2938
Preformed Line Products
PLPC
$946M
| $585K | ﹤0.01% |
9,791
+58
| +0.6% | +$3.47K |
|
2939
Distribution Solutions Group
DSGR
$1.48B
| $583K | ﹤0.01% |
30,676
+188
| +0.6% | +$3.57K |
|
2940
Nathan's Famous
NATH
$429M
| $583K | ﹤0.01% |
10,075
+116
| +1% | +$6.71K |
|
|
ROVR
2941
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $583K | ﹤0.01% |
+102,881
| New | +$583K |
|
|
PINE
2942
Alpine Income Property Trust
PINE
$219M
| $582K | ﹤0.01% |
31,129
-61,271
| -66% | -$1.15M |
|
|
OMIC
2943
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $579K | ﹤0.01% |
3,045
+2,541
| +504% | +$483K |
|
2944
BioAtla
BCAB
$31.5M
| $572K | ﹤0.01% |
104,744
+52,539
| +101% | +$287K |
|
|
INST
2945
DELISTED
Instructure Holdings, Inc.
INST
| $572K | ﹤0.01% |
28,922
-1,203
| -4% | -$23.8K |
|
2946
Avita Medical
RCEL
$115M
| $571K | ﹤0.01% |
73,768
+540
| +0.7% | +$4.18K |
|
2947
Ryanair
RYAAY
$32.1B
| $571K | ﹤0.01% |
16,395
| – | – |
|
2948
Annexon
ANNX
$238M
| $570K | ﹤0.01% |
166,803
+56,395
| +51% | +$193K |
|
2949
First Bank
FRBA
$421M
| $570K | ﹤0.01% |
40,158
+657
| +2% | +$9.33K |
|
2950
Xponential Fitness
XPOF
$299M
| $569K | ﹤0.01% |
24,382
+12,982
| +114% | +$303K |
|